With its stock down 15% over the past three months, it is easy to disregard CML Microsystems (LON:CML). Given that stock ...

Receiving a diagnosis of Chronic Myeloid Leukemia (CML) can be frightening, but it is important to understand that the management of this disease is one of the greatest success stories in modern ...

An advocate discusses vital patient-provider conversations to promote the best care for individuals with chronic myeloid leukemia. Receiving a diagnosis of chronic myeloid leukemia (CML) can be ...

CML Micro has launched the CMX918, an ultra‑low‑power, multi‑mode Software‑Defined Radio (SDR) tuner designed to extend ...

Results from the phase 3 ENDURE trial (NCT03117816), newly published in Leukemia, demonstrate that ropeginterferon alfa-2b ...

Novartis is in Chicago for the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and has brought along an interactive experience for the weekend. The Swiss drugmaker is rolling out its ...

Newly published data suggests most patients are opting for second- or third-generation tyrosine kinase inhibitors instead of a generic form of imatinib. Patients with chronic myelogenous leukemia (CML ...

Chronic myeloid leukemia (CML) is a type of cancer that causes blood cells to grow out of control. If you’ve been diagnosed with CML, it’s important to get treatment from healthcare professionals who ...

Please provide your email address to receive an email when new articles are posted on . It has been eight years since imatinib was approved as the first oral tyrosine kinase inhibitor indicated for ...

LONDON--(BUSINESS WIRE)--The global chronic myelogenous leukemia (CML) therapeutics market size is poised to grow by USD 1.74 billion during 2019-2023, according to a new report by Technavio, ...

Roman Reigns discussed his return to WWE last week following his battle with leukemia on the latest episode of Chronicle, which premiered Monday night on the WWE Network. During the episode, Reigns ...